Jessica M Best Selected Research

berotralstat

6/2021	Long-term safety and effectiveness of berotralstat for hereditary angioedema: The open-label APeX-S study.
1/2021	Oral berotralstat for the prophylaxis of hereditary angioedema attacks in patients in Japan: A phase 3 randomized trial.
1/2021	Randomized Trial of the Efficacy and Safety of Berotralstat (BCX7353) as an Oral Prophylactic Therapy for Hereditary Angioedema: Results of APeX-2 Through 48 Weeks (Part 2).
1/2021	Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jessica M Best Research Topics

Disease

5	Hereditary Angioedemas 06/2021 - 01/2021
2	Angioedema 06/2021 - 01/2021
2	Diarrhea 01/2021 - 01/2021
2	Abdominal Pain (Pain, Abdominal) 01/2021 - 01/2021
1	Back Pain (Backache) 01/2021
1	Vomiting 01/2021
1	Nasopharyngitis 01/2021
1	Cough 01/2021
1	Fever (Fevers) 01/2021

Drug/Important Bio-Agent (IBA)

4	berotralstatIBA 06/2021 - 01/2021
3	Plasma KallikreinIBA 06/2021 - 01/2021
1	Kallikreins (Kallikrein)IBA 01/2021

Therapy/Procedure

2	Therapeutics 01/2021 - 01/2021
1	Injections 01/2021